Data as of Nov 26
| +0.09 / +0.26%|
The 9 analysts offering 12-month price forecasts for Auxilium Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 34.00 and a low estimate of 21.00. The median estimate represents a -3.73% decrease from the last price of 34.28.
The current consensus among 10 polled investment analysts is to Hold stock in Auxilium Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.